Advertisement
Screener

PRINCIPIA BIOPHARMA INC. Operating Cash Flow

PRINCIPIA BIOPHARMA INC. Operating Cash Flow

PRINCIPIA BIOPHARMA INC. reported Operating Cash Flow of -$54.43 million for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2020-08-06

  • PRINCIPIA BIOPHARMA INC. net cash provided by (used in) operating activities for the quarter ending 2020-06-30 was -$26.95M, a 293.61% decline year-over-year.
  • PRINCIPIA BIOPHARMA INC. net cash provided by (used in) operating activities for the quarter ending 2020-03-31 was -$27.47M.
  • PRINCIPIA BIOPHARMA INC. net cash provided by (used in) operating activities for the quarter ending 2019-12-31 was -$21.68M.
  • PRINCIPIA BIOPHARMA INC. net cash provided by (used in) operating activities for the quarter ending 2019-09-30 was -$18.38M, a 390.69% decline year-over-year.
  • PRINCIPIA BIOPHARMA INC. net cash provided by (used in) operating activities for fiscal 2019 was -$42.55M.
  • PRINCIPIA BIOPHARMA INC. net cash provided by (used in) operating activities for fiscal 2018 was -$21.17M, a 178.86% decline from fiscal 2017.
  • PRINCIPIA BIOPHARMA INC. net cash provided by (used in) operating activities for fiscal 2017 was $26.85M.
  • PRINCIPIA BIOPHARMA INC. net cash provided by (used in) operating activities for fiscal 2016 was -$24.84M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 month
2020-06-30-$26.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$54.43M
10-Q · filed 2020-08-06
-$76.11M
derived: sum of 3 quarters · filed 2020-08-06
-$94.49M
derived: sum of 4 quarters · filed 2020-08-06
2020-03-31-$27.47M
10-Q · filed 2020-05-06
-$49.15M
derived: sum of 2 quarters · filed 2020-05-06
-$67.53M
derived: sum of 3 quarters · filed 2020-05-06
-$53.61M
derived: sum of 4 quarters · filed 2020-08-06
2019-12-31-$21.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
-$40.06M
derived: sum of 2 quarters · filed 2020-03-10
-$26.14M
derived: sum of 3 quarters · filed 2020-08-06
-$42.55M
10-K · filed 2020-03-10
2019-09-30-$18.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$4.46M
derived: sum of 2 quarters · filed 2020-08-06
-$20.87M
10-Q · filed 2019-11-05
-$26.64M
derived: sum of 4 quarters · filed 2020-08-06
2019-06-30$13.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$2.48M
10-Q · filed 2020-08-06
-$8.26M
derived: sum of 3 quarters · filed 2020-08-06
-$1.94M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31-$16.41M
10-Q · filed 2020-05-06
-$22.18M
derived: sum of 2 quarters · filed 2020-05-06
-$15.86M
derived: sum of 3 quarters · filed 2020-05-06
-$26.55M
derived: sum of 4 quarters · filed 2020-05-06
2018-12-31-$5.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$548.00K
derived: sum of 2 quarters · filed 2020-03-10
-$10.15M
derived: sum of 3 quarters · filed 2020-03-10
-$21.17M
10-K · filed 2020-03-10
2018-09-30$6.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$4.37M
derived: sum of 2 quarters · filed 2019-11-05
-$15.40M
10-Q · filed 2019-11-05
-$15.86M
10-Q · filed 2018-11-06
$17.83M
derived: sum of 4 quarters · filed 2020-03-10
2018-06-30-$10.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$21.72M
10-Q · filed 2019-08-08
$11.50M
derived: sum of 3 quarters · filed 2020-03-10
2018-03-31-$11.03M
10-Q · filed 2019-05-07
$22.20M
derived: sum of 2 quarters · filed 2020-03-10
2017-12-31$33.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$26.85M
10-K · filed 2020-03-10
2017-09-30-$6.38M
10-Q · filed 2018-11-06
2016-12-31-$24.84M
10-K · filed 2019-03-19